Dr. Makoto Abue, MD, PhD, is the current head of the Department of Gastroenterology at Miyagi Cancer Center in Japan. Dr. Abue has extensive clinical experience and is deeply immersed in the daily challenges of treating pancreatic diseases using endoscopic and chemotherapeutic modalities. His primary professional aspiration is to improve the prognosis of pancreatic cancer patients. This passion drives his research, which focuses on critical areas such as identifying biomarkers for early diagnosis, developing advanced methods for prognostic prediction, and optimizing therapeutic interventions for pancreatic cancer. Dr. Abue's academic contributions include the study, "Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer." He is an active member of the Japanese Cancer Association, the Japanese Society of Gastroenterology, and the Japan Pancreatic Society. Research Keywords: Pancreatic cancer Early diagnosis Prognostic prediction Biomarkers Clinical Oncology